Hims & Hers (HIMS) is down -25.8%, or -$5.95 to $17.07.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Video: SoFi among early risers after Citizens upgrade
- Morning Movers: Hims & Hers drops after deciding to stop selling Wegovy copycat
- Hims & Hers says Novo Nordisk lawsuit ‘blatant attack’ on millions of Americans
- Novo Nordisk sues Hims & Hers over Wegovy pill, injection copycats, CNBC reports
- Hims & Hers price target lowered to $20 from $30 at TD Cowen